hotspot -WSS

hotspot

author：hotspot 2025-09-27 10:04:55 - browse：22469

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Surgery pushed Ben Carson to fame

entertainment

WSS

No plane should take off without an EpiPen onboard

Lawsuit alleges UnitedHealth Group unit illegally denied claims

The Biogen Aduhelm mess could happen again

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Sage hopes for a blockbuster in antidepressant now before FDA

focus

hotspot

focus

Psychedelics group wrestles with new pharma identity

Mega Millions pot grows to $1.25 billion after no winner

Tori Bowie and the unacceptable rates of Black maternal death

What’s missing from the debate over nursing home staff minimums

At least 13 dead in Texas as scorching temps continue

A single Democrat is willing to weaken Medicare negotiation power

Continuity nursing helped my family in our darkest PICU moments

Adults seen as increasingly susceptible to measles

Guidelines to prevent youth baseball injuries need more muscle

EQRx, failed developer of low

hotspot

Adopting new red light myopia treatments may be short

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Johnson & Johnson sued for allegedly overpaying for workers' drugs

‘Oppenheimer’ and the risks of AI in health care

The CDC's new social media misinformation war

Why CTE doesn’t keep Americans from enjoying the Super Bowl

entertainment

hotspot

leisure time

hotspot